

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.01435887 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.01435887 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.56663292 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.49874172 |
| 5 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.15365734 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92239644 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.55216557 |
| 8 | negative regulation of viral genome replication (GO:0045071) | 4.42889197 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.42089944 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.42089944 |
| 11 | cellular response to interferon-alpha (GO:0035457) | 4.35462833 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 4.32600775 |
| 13 | cellular response to zinc ion (GO:0071294) | 4.23744305 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.23137860 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.03702334 |
| 16 | response to interferon-beta (GO:0035456) | 4.02003873 |
| 17 | response to type I interferon (GO:0034340) | 4.01340106 |
| 18 | type I interferon signaling pathway (GO:0060337) | 3.99536486 |
| 19 | cellular response to type I interferon (GO:0071357) | 3.99536486 |
| 20 | leukocyte aggregation (GO:0070486) | 3.98168021 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97859543 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97859543 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.97859543 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97859543 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.97859543 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97859543 |
| 27 | DNA deamination (GO:0045006) | 3.96652896 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.92925299 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92755018 |
| 30 | positive regulation of lamellipodium assembly (GO:0010592) | 3.81814497 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.80264498 |
| 32 | detection of bacterium (GO:0016045) | 3.79430794 |
| 33 | negative regulation of phagocytosis (GO:0050765) | 3.70781444 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.65123481 |
| 35 | detection of other organism (GO:0098543) | 3.64499237 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.63145898 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.60048788 |
| 38 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.55225193 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.54883764 |
| 40 | response to peptidoglycan (GO:0032494) | 3.51658122 |
| 41 | response to interferon-alpha (GO:0035455) | 3.42921840 |
| 42 | response to protozoan (GO:0001562) | 3.39868865 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36431975 |
| 44 | cellular response to interferon-beta (GO:0035458) | 3.36088243 |
| 45 | positive regulation of macrophage differentiation (GO:0045651) | 3.35540309 |
| 46 | T cell migration (GO:0072678) | 3.35108039 |
| 47 | mast cell activation (GO:0045576) | 3.32352573 |
| 48 | defense response to protozoan (GO:0042832) | 3.31766260 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.29015571 |
| 50 | B cell mediated immunity (GO:0019724) | 3.26168071 |
| 51 | viral transcription (GO:0019083) | 3.22941670 |
| 52 | positive regulation of lamellipodium organization (GO:1902745) | 3.21766769 |
| 53 | cellular response to virus (GO:0098586) | 3.19645026 |
| 54 | response to interleukin-15 (GO:0070672) | 3.17630333 |
| 55 | hepatocyte apoptotic process (GO:0097284) | 3.16552244 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.14697237 |
| 57 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.14297569 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.12100171 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10227115 |
| 60 | regulation of respiratory burst (GO:0060263) | 3.08874421 |
| 61 | translational termination (GO:0006415) | 3.04516605 |
| 62 | response to host (GO:0075136) | 3.04109311 |
| 63 | response to host defenses (GO:0052200) | 3.04109311 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.04109311 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03470589 |
| 66 | detection of external biotic stimulus (GO:0098581) | 3.02689265 |
| 67 | cellular response to interleukin-15 (GO:0071350) | 3.02187737 |
| 68 | regulation of necroptotic process (GO:0060544) | 3.01500781 |
| 69 | regulation of response to interferon-gamma (GO:0060330) | 3.00943354 |
| 70 | COPI coating of Golgi vesicle (GO:0048205) | 3.00454560 |
| 71 | Golgi transport vesicle coating (GO:0048200) | 3.00454560 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.00041063 |
| 73 | sequestering of actin monomers (GO:0042989) | 2.99762752 |
| 74 | T cell homeostasis (GO:0043029) | 2.99574777 |
| 75 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.99494894 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 2.99294867 |
| 77 | response to host immune response (GO:0052572) | 2.98879346 |
| 78 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98879346 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.96221905 |
| 80 | regulation of viral genome replication (GO:0045069) | 2.96208022 |
| 81 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95329744 |
| 82 | negative regulation of innate immune response (GO:0045824) | 2.94833260 |
| 83 | negative T cell selection (GO:0043383) | 2.94675860 |
| 84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.92846384 |
| 85 | negative regulation of viral process (GO:0048525) | 2.92800018 |
| 86 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.92629012 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91362521 |
| 88 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.90974718 |
| 89 | respiratory burst (GO:0045730) | 2.88637033 |
| 90 | actin nucleation (GO:0045010) | 2.84453007 |
| 91 | negative regulation of viral entry into host cell (GO:0046597) | 2.84347399 |
| 92 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83839681 |
| 93 | regulation of interferon-alpha production (GO:0032647) | 2.83752561 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.83377780 |
| 95 | cotranslational protein targeting to membrane (GO:0006613) | 2.81805073 |
| 96 | protein targeting to ER (GO:0045047) | 2.81291995 |
| 97 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79939124 |
| 98 | positive regulation of type 2 immune response (GO:0002830) | 2.79642751 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.79533457 |
| 100 | neutrophil activation involved in immune response (GO:0002283) | 2.78121424 |
| 101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77533251 |
| 102 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73879414 |
| 103 | leukocyte cell-cell adhesion (GO:0007159) | 2.72468494 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.72293075 |
| 105 | defense response to virus (GO:0051607) | 2.71813751 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.71515103 |
| 107 | regulation of defense response to virus by virus (GO:0050690) | 2.69855495 |
| 108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69610957 |
| 109 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69009057 |
| 110 | mature B cell differentiation involved in immune response (GO:0002313) | 2.68681087 |
| 111 | negative regulation of viral release from host cell (GO:1902187) | 2.68340406 |
| 112 | regulation of type 2 immune response (GO:0002828) | 2.68281625 |
| 113 | cellular response to interferon-gamma (GO:0071346) | 2.68036442 |
| 114 | protein localization to endoplasmic reticulum (GO:0070972) | 2.66900273 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.66750412 |
| 116 | thymic T cell selection (GO:0045061) | 2.64816378 |
| 117 | lymphocyte homeostasis (GO:0002260) | 2.64357934 |
| 118 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.63997918 |
| 119 | translational elongation (GO:0006414) | 2.63801593 |
| 120 | regulation of necrotic cell death (GO:0010939) | 2.62875132 |
| 121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62610724 |
| 122 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62209062 |
| 123 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.61646834 |
| 124 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.61646834 |
| 125 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.60892628 |
| 126 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60637571 |
| 127 | response to interferon-gamma (GO:0034341) | 2.60244244 |
| 128 | T cell costimulation (GO:0031295) | 2.60172777 |
| 129 | lymphocyte costimulation (GO:0031294) | 2.59530322 |
| 130 | tolerance induction (GO:0002507) | 2.59530301 |
| 131 | protein localization to endosome (GO:0036010) | 2.59041042 |
| 132 | lymph node development (GO:0048535) | 2.58870710 |
| 133 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.58203578 |
| 134 | definitive hemopoiesis (GO:0060216) | 2.57967693 |
| 135 | angiogenesis involved in wound healing (GO:0060055) | 2.57213060 |
| 136 | T cell receptor signaling pathway (GO:0050852) | 2.56423316 |
| 137 | interferon-gamma production (GO:0032609) | 2.55991688 |
| 138 | cellular response to exogenous dsRNA (GO:0071360) | 2.55042333 |
| 139 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.54786669 |
| 140 | detection of biotic stimulus (GO:0009595) | 2.54091997 |
| 141 | interferon-gamma secretion (GO:0072643) | 2.54079278 |
| 142 | cytidine metabolic process (GO:0046087) | 2.53811854 |
| 143 | cytidine catabolic process (GO:0006216) | 2.53811854 |
| 144 | cytidine deamination (GO:0009972) | 2.53811854 |
| 145 | lymphocyte chemotaxis (GO:0048247) | 2.51418497 |
| 146 | ribosomal small subunit biogenesis (GO:0042274) | 2.50012886 |
| 147 | Peyers patch development (GO:0048541) | 2.49469428 |
| 148 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.49469428 |
| 149 | regulation of viral entry into host cell (GO:0046596) | 2.49465062 |
| 150 | cellular extravasation (GO:0045123) | 2.49427753 |
| 151 | myeloid dendritic cell differentiation (GO:0043011) | 2.48711387 |
| 152 | neutrophil activation (GO:0042119) | 2.47705516 |
| 153 | granulocyte activation (GO:0036230) | 2.46937870 |
| 154 | germinal center formation (GO:0002467) | 2.46874154 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.46681164 |
| 156 | barbed-end actin filament capping (GO:0051016) | 2.45868525 |
| 157 | regulation of tolerance induction (GO:0002643) | 2.44972627 |
| 158 | pinocytosis (GO:0006907) | 2.44261957 |
| 159 | mast cell activation involved in immune response (GO:0002279) | 2.43316689 |
| 160 | mast cell degranulation (GO:0043303) | 2.43316689 |
| 161 | viral life cycle (GO:0019058) | 2.43218066 |
| 162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.42612399 |
| 163 | natural killer cell activation (GO:0030101) | 2.42593169 |
| 164 | negative regulation of defense response to virus (GO:0050687) | 2.41449969 |
| 165 | negative regulation of type 2 immune response (GO:0002829) | 2.40843248 |
| 166 | modulation by symbiont of host cellular process (GO:0044068) | 2.40464592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.10153493 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72591465 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60272619 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.50181370 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37125657 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.35389277 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17626416 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02386649 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99989847 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.75926056 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68384472 |
| 12 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.62895501 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60436250 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55496080 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55351564 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54920933 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49963197 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44819614 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.43102323 |
| 20 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.42668999 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33235327 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.31690086 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.29059345 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27923115 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22642817 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20692391 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17927977 |
| 28 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17609650 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17428215 |
| 30 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15384281 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.09870554 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08997310 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06370171 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 2.05201296 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98718757 |
| 36 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95446223 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95199002 |
| 38 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.94901244 |
| 39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94370830 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91003288 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86418789 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79746164 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79126570 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73044802 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68744678 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66041088 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61654540 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60959135 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59924591 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57080914 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54817548 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54439355 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54409216 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50937099 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49100162 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46317713 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44628627 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.44290193 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40937212 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40279227 |
| 61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.39175993 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38731767 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38113999 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36774918 |
| 65 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.36616677 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36367856 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35703845 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.35388784 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34574796 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32320971 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31070454 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30460355 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29692324 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29157851 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26779852 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26524985 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25986386 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24304089 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23803203 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23332963 |
| 81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23297207 |
| 82 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23042177 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22651187 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21124027 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20768894 |
| 86 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20318513 |
| 87 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18653867 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14712898 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14142530 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12511064 |
| 91 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12398693 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12011249 |
| 93 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.11973836 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11853890 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11680319 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11609198 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10938533 |
| 98 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10889183 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10243348 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09396739 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09362810 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09158272 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08691130 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08479001 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08144853 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07087146 |
| 107 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06312444 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05890102 |
| 109 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05745120 |
| 110 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04815599 |
| 111 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04415653 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03988275 |
| 113 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03465186 |
| 114 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03454710 |
| 115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02888573 |
| 116 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.01573326 |
| 117 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00363164 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99578777 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99437747 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98259200 |
| 121 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98060359 |
| 122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98006327 |
| 123 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95883070 |
| 124 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.95533087 |
| 125 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94749403 |
| 126 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.94734018 |
| 127 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93537955 |
| 128 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93053594 |
| 129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91957722 |
| 130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91562371 |
| 131 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.91424911 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91270391 |
| 133 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90338518 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89093786 |
| 135 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88609049 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87310482 |
| 137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85169154 |
| 138 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.84277059 |
| 139 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84057885 |
| 140 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.83859691 |
| 141 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.81392399 |
| 142 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.81095248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.38883173 |
| 2 | MP0000685_abnormal_immune_system | 3.50498627 |
| 3 | MP0005671_abnormal_response_to | 3.36394197 |
| 4 | MP0009785_altered_susceptibility_to | 3.26884392 |
| 5 | MP0003724_increased_susceptibility_to | 3.00262049 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.91602575 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.90408156 |
| 8 | MP0005387_immune_system_phenotype | 2.83704926 |
| 9 | MP0001790_abnormal_immune_system | 2.83704926 |
| 10 | MP0001800_abnormal_humoral_immune | 2.83010115 |
| 11 | MP0005025_abnormal_response_to | 2.72893083 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.63042526 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.57464170 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.54040586 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.49369398 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.47013782 |
| 17 | MP0002723_abnormal_immune_serum | 2.46488220 |
| 18 | MP0001819_abnormal_immune_cell | 2.44450003 |
| 19 | MP0003436_decreased_susceptibility_to | 2.42477595 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.35805325 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 2.33799347 |
| 22 | MP0002398_abnormal_bone_marrow | 2.29788931 |
| 23 | MP0002006_tumorigenesis | 2.29550335 |
| 24 | MP0002419_abnormal_innate_immunity | 2.27262912 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.17967345 |
| 26 | MP0000716_abnormal_immune_system | 2.10996736 |
| 27 | MP0002405_respiratory_system_inflammati | 2.09190977 |
| 28 | MP0001873_stomach_inflammation | 2.06320422 |
| 29 | MP0001853_heart_inflammation | 2.05500890 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.02671999 |
| 31 | MP0005451_abnormal_body_composition | 1.99471298 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.99320312 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.97588171 |
| 34 | MP0006082_CNS_inflammation | 1.94710631 |
| 35 | MP0002722_abnormal_immune_system | 1.90393840 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.89536075 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.89536075 |
| 38 | MP0008260_abnormal_autophagy | 1.88560854 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.88037198 |
| 40 | MP0002429_abnormal_blood_cell | 1.80924545 |
| 41 | MP0004947_skin_inflammation | 1.79407911 |
| 42 | MP0003303_peritoneal_inflammation | 1.77360597 |
| 43 | MP0009840_abnormal_foam_cell | 1.75616162 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.74673042 |
| 45 | MP0003866_abnormal_defecation | 1.69509314 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.65711225 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.62768609 |
| 48 | MP0009278_abnormal_bone_marrow | 1.62218527 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.61678136 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.56500921 |
| 51 | MP0000490_abnormal_crypts_of | 1.52709578 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.52653780 |
| 53 | MP0001958_emphysema | 1.51669518 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.49394969 |
| 55 | MP0000858_altered_metastatic_potential | 1.45086705 |
| 56 | MP0008469_abnormal_protein_level | 1.41125436 |
| 57 | MP0006054_spinal_hemorrhage | 1.35876873 |
| 58 | MP0004858_abnormal_nervous_system | 1.31698723 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.31159498 |
| 60 | MP0002933_joint_inflammation | 1.30350191 |
| 61 | MP0004510_myositis | 1.26346263 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.24114480 |
| 63 | MP0005390_skeleton_phenotype | 1.23750082 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.23341240 |
| 65 | MP0005310_abnormal_salivary_gland | 1.22594136 |
| 66 | MP0000343_altered_response_to | 1.22233359 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.20082610 |
| 68 | MP0001542_abnormal_bone_strength | 1.19266224 |
| 69 | MP0002796_impaired_skin_barrier | 1.18884603 |
| 70 | MP0003279_aneurysm | 1.18747814 |
| 71 | MP0009764_decreased_sensitivity_to | 1.18529131 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.13758733 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.13563532 |
| 74 | MP0001849_ear_inflammation | 1.12589525 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.12184961 |
| 76 | MP0004381_abnormal_hair_follicle | 1.11211268 |
| 77 | MP0005083_abnormal_biliary_tract | 1.10586264 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 1.10255279 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 1.06089424 |
| 80 | MP0003091_abnormal_cell_migration | 1.05725320 |
| 81 | MP0003448_altered_tumor_morphology | 1.05624559 |
| 82 | MP0002060_abnormal_skin_morphology | 1.01667126 |
| 83 | MP0005058_abnormal_lysosome_morphology | 1.01452200 |
| 84 | MP0002132_abnormal_respiratory_system | 0.97216282 |
| 85 | MP0003045_fibrosis | 0.96939900 |
| 86 | MP0000604_amyloidosis | 0.96176868 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.95438368 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.94910927 |
| 89 | MP0001851_eye_inflammation | 0.94654517 |
| 90 | MP0003828_pulmonary_edema | 0.94524677 |
| 91 | MP0005023_abnormal_wound_healing | 0.89506360 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.89426523 |
| 93 | MP0009763_increased_sensitivity_to | 0.88111706 |
| 94 | MP0003795_abnormal_bone_structure | 0.87461765 |
| 95 | MP0005164_abnormal_response_to | 0.87087489 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.86429114 |
| 97 | MP0005501_abnormal_skin_physiology | 0.85538129 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.84634537 |
| 99 | MP0003329_amyloid_beta_deposits | 0.83361025 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.82342010 |
| 101 | MP0000249_abnormal_blood_vessel | 0.82218483 |
| 102 | MP0001879_abnormal_lymphatic_vessel | 0.82102006 |
| 103 | MP0001243_abnormal_dermal_layer | 0.81713392 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.81695052 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.79978042 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.79383354 |
| 107 | MP0004883_abnormal_blood_vessel | 0.77145273 |
| 108 | MP0008874_decreased_physiological_sensi | 0.77095313 |
| 109 | MP0003186_abnormal_redox_activity | 0.77026584 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.75933207 |
| 111 | MP0008057_abnormal_DNA_replication | 0.75832681 |
| 112 | MP0001663_abnormal_digestive_system | 0.74431006 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.74085213 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.71121779 |
| 115 | MP0005166_decreased_susceptibility_to | 0.70409192 |
| 116 | MP0010094_abnormal_chromosome_stability | 0.69208234 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.68712946 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.68008556 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.66442311 |
| 120 | MP0003075_altered_response_to | 0.66070223 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.65999492 |
| 122 | MP0002009_preneoplasia | 0.64977891 |
| 123 | MP0002254_reproductive_system_inflammat | 0.64164604 |
| 124 | MP0000015_abnormal_ear_pigmentation | 0.62500859 |
| 125 | MP0001881_abnormal_mammary_gland | 0.62234948 |
| 126 | MP0010234_abnormal_vibrissa_follicle | 0.61813313 |
| 127 | MP0000609_abnormal_liver_physiology | 0.61674849 |
| 128 | MP0003077_abnormal_cell_cycle | 0.60284680 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.59855037 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.59014342 |
| 131 | MP0000598_abnormal_liver_morphology | 0.58955175 |
| 132 | MP0000313_abnormal_cell_death | 0.58682599 |
| 133 | MP0002928_abnormal_bile_duct | 0.58054295 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.55066214 |
| 135 | MP0008873_increased_physiological_sensi | 0.54248652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.16072174 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.76302508 |
| 3 | Chronic otitis media (HP:0000389) | 4.64908743 |
| 4 | IgM deficiency (HP:0002850) | 4.58521893 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.32188154 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.23072118 |
| 7 | Myositis (HP:0100614) | 4.06797912 |
| 8 | Agammaglobulinemia (HP:0004432) | 4.01940749 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.88026512 |
| 10 | Thrombocytosis (HP:0001894) | 3.80696683 |
| 11 | Abnormality of T cell physiology (HP:0011840) | 3.78851919 |
| 12 | IgG deficiency (HP:0004315) | 3.64923704 |
| 13 | Recurrent viral infections (HP:0004429) | 3.62662074 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.62519750 |
| 15 | Pustule (HP:0200039) | 3.61887667 |
| 16 | Abnormality of T cells (HP:0002843) | 3.61778354 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 3.61057369 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 3.52323487 |
| 19 | Nasal polyposis (HP:0100582) | 3.51429267 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44008515 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44008515 |
| 22 | Meningitis (HP:0001287) | 3.36837771 |
| 23 | Severe combined immunodeficiency (HP:0004430) | 3.36263110 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.30459022 |
| 25 | Abnormality of B cell number (HP:0010975) | 3.27898831 |
| 26 | B lymphocytopenia (HP:0010976) | 3.27898831 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.26681991 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.23613187 |
| 29 | Cellulitis (HP:0100658) | 3.23022390 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.17786253 |
| 31 | Thyroiditis (HP:0100646) | 3.13278745 |
| 32 | T lymphocytopenia (HP:0005403) | 3.12600660 |
| 33 | Recurrent skin infections (HP:0001581) | 3.11599880 |
| 34 | Colitis (HP:0002583) | 3.06840511 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.06744594 |
| 36 | Combined immunodeficiency (HP:0005387) | 3.03839970 |
| 37 | Lymphopenia (HP:0001888) | 3.00295175 |
| 38 | Hypoplasia of the thymus (HP:0000778) | 2.98827760 |
| 39 | Premature rupture of membranes (HP:0001788) | 2.98227123 |
| 40 | Stomatitis (HP:0010280) | 2.96451914 |
| 41 | Protrusio acetabuli (HP:0003179) | 2.95132878 |
| 42 | Petechiae (HP:0000967) | 2.94020551 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.92585312 |
| 44 | Increased IgM level (HP:0003496) | 2.92498563 |
| 45 | IgA deficiency (HP:0002720) | 2.91559646 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90406406 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.89719026 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.88468615 |
| 49 | Vasculitis (HP:0002633) | 2.87386798 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82354980 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82354980 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82354980 |
| 53 | Bronchitis (HP:0012387) | 2.77108842 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.74340730 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.72641783 |
| 56 | Chronic diarrhea (HP:0002028) | 2.71933637 |
| 57 | Chronic sinusitis (HP:0011109) | 2.69507428 |
| 58 | Orchitis (HP:0100796) | 2.62852875 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.62789919 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.61973451 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.58664443 |
| 62 | Abnormal number of erythroid precursors (HP:0012131) | 2.57313837 |
| 63 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.57120615 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56207986 |
| 65 | Obstructive lung disease (HP:0006536) | 2.56207986 |
| 66 | Distal lower limb muscle weakness (HP:0009053) | 2.53359239 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52544515 |
| 68 | Poikiloderma (HP:0001029) | 2.48038907 |
| 69 | Reticulocytopenia (HP:0001896) | 2.47679240 |
| 70 | Epistaxis (HP:0000421) | 2.47388563 |
| 71 | Cervical subluxation (HP:0003308) | 2.47263404 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.46690969 |
| 73 | Abnormal platelet function (HP:0011869) | 2.46690969 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.44962020 |
| 75 | Aplastic anemia (HP:0001915) | 2.44536230 |
| 76 | Abnormality of eosinophils (HP:0001879) | 2.42911560 |
| 77 | Purpura (HP:0000979) | 2.42603526 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.41731622 |
| 79 | Lymphoma (HP:0002665) | 2.40752497 |
| 80 | Urticaria (HP:0001025) | 2.40660605 |
| 81 | Gastrointestinal infarctions (HP:0005244) | 2.39627125 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.37695566 |
| 83 | Osteomyelitis (HP:0002754) | 2.37062135 |
| 84 | Loss of speech (HP:0002371) | 2.36846617 |
| 85 | Emphysema (HP:0002097) | 2.34487344 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.32839498 |
| 87 | Leukocytosis (HP:0001974) | 2.32429855 |
| 88 | Periodontitis (HP:0000704) | 2.31675794 |
| 89 | Skin ulcer (HP:0200042) | 2.29191778 |
| 90 | Hemoptysis (HP:0002105) | 2.27844100 |
| 91 | Gingivitis (HP:0000230) | 2.26488351 |
| 92 | Hypertensive crisis (HP:0100735) | 2.21311717 |
| 93 | Eosinophilia (HP:0001880) | 2.21218333 |
| 94 | Skin rash (HP:0000988) | 2.19889526 |
| 95 | Peritonitis (HP:0002586) | 2.19674154 |
| 96 | Granulocytopenia (HP:0001913) | 2.19660169 |
| 97 | Increased connective tissue (HP:0009025) | 2.19238678 |
| 98 | Sepsis (HP:0100806) | 2.18481632 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.17684644 |
| 100 | Optic neuritis (HP:0100653) | 2.17232191 |
| 101 | Retrobulbar optic neuritis (HP:0100654) | 2.17232191 |
| 102 | Verrucae (HP:0200043) | 2.16904926 |
| 103 | Papilloma (HP:0012740) | 2.16904926 |
| 104 | Abnormality of the fingertips (HP:0001211) | 2.13911770 |
| 105 | Hypoproteinemia (HP:0003075) | 2.12260492 |
| 106 | Increased serum ferritin (HP:0003281) | 2.12147436 |
| 107 | Microcytic anemia (HP:0001935) | 2.09709614 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 2.09591424 |
| 109 | Reduced antithrombin III activity (HP:0001976) | 2.08931345 |
| 110 | Recurrent pneumonia (HP:0006532) | 2.07022435 |
| 111 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06367665 |
| 112 | Pulmonary infiltrates (HP:0002113) | 2.04981778 |
| 113 | Hepatosplenomegaly (HP:0001433) | 2.04647900 |
| 114 | Abnormality of the prostate (HP:0008775) | 2.03941205 |
| 115 | Encephalitis (HP:0002383) | 2.02175653 |
| 116 | Polygenic inheritance (HP:0010982) | 2.01719407 |
| 117 | Abnormality of the pericardium (HP:0001697) | 2.00355839 |
| 118 | Increased IgE level (HP:0003212) | 2.00018107 |
| 119 | Cheilitis (HP:0100825) | 1.99902217 |
| 120 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.99872301 |
| 121 | Systemic lupus erythematosus (HP:0002725) | 1.98010547 |
| 122 | Amyloidosis (HP:0011034) | 1.97756829 |
| 123 | J-shaped sella turcica (HP:0002680) | 1.97177643 |
| 124 | Hematochezia (HP:0002573) | 1.96454436 |
| 125 | Neutropenia (HP:0001875) | 1.96118037 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94622484 |
| 127 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94587370 |
| 128 | Gingival bleeding (HP:0000225) | 1.94334544 |
| 129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93224384 |
| 130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93224384 |
| 131 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93224384 |
| 132 | Progressive neurologic deterioration (HP:0002344) | 1.92385517 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89007958 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.89007958 |
| 135 | Abnormality of the peritoneum (HP:0002585) | 1.85768211 |
| 136 | Ankle contracture (HP:0006466) | 1.85116619 |
| 137 | Distal lower limb amyotrophy (HP:0008944) | 1.82846906 |
| 138 | Premature loss of primary teeth (HP:0006323) | 1.82577205 |
| 139 | Achilles tendon contracture (HP:0001771) | 1.82494724 |
| 140 | Fragile skin (HP:0001030) | 1.82243766 |
| 141 | Hypochromic anemia (HP:0001931) | 1.79945433 |
| 142 | Keratoconjunctivitis sicca (HP:0001097) | 1.79437244 |
| 143 | Upper limb amyotrophy (HP:0009129) | 1.78823470 |
| 144 | Distal upper limb amyotrophy (HP:0007149) | 1.78823470 |
| 145 | Hyperacusis (HP:0010780) | 1.78396022 |
| 146 | Rough bone trabeculation (HP:0100670) | 1.77801410 |
| 147 | Chest pain (HP:0100749) | 1.76648207 |
| 148 | Hypertriglyceridemia (HP:0002155) | 1.76259052 |
| 149 | Episodic fever (HP:0001954) | 1.75966591 |
| 150 | Biconcave vertebral bodies (HP:0004586) | 1.74564895 |
| 151 | Blue sclerae (HP:0000592) | 1.73989569 |
| 152 | Restrictive lung disease (HP:0002091) | 1.73224203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.55128637 |
| 2 | TRIB3 | 3.31568105 |
| 3 | KDR | 3.11513729 |
| 4 | KIT | 2.67362761 |
| 5 | ZAP70 | 2.61674971 |
| 6 | TXK | 2.61389187 |
| 7 | ERN1 | 2.60581883 |
| 8 | MAP3K12 | 2.58827187 |
| 9 | SMG1 | 2.58055514 |
| 10 | BLK | 2.55482893 |
| 11 | PRPF4B | 2.50476673 |
| 12 | IKBKE | 2.44504605 |
| 13 | TYK2 | 2.39609754 |
| 14 | TBK1 | 2.35789388 |
| 15 | JAK3 | 2.24623186 |
| 16 | BTK | 2.15132896 |
| 17 | NME2 | 2.05586816 |
| 18 | TEC | 2.02845222 |
| 19 | TGFBR2 | 1.99787069 |
| 20 | FGFR4 | 1.91865349 |
| 21 | IRAK4 | 1.85204137 |
| 22 | TESK2 | 1.84002270 |
| 23 | PIM2 | 1.80937580 |
| 24 | MAP3K3 | 1.70743903 |
| 25 | MAP3K14 | 1.70374541 |
| 26 | SYK | 1.65699505 |
| 27 | STK10 | 1.57442554 |
| 28 | CSF1R | 1.52296748 |
| 29 | TAOK2 | 1.51395557 |
| 30 | JAK1 | 1.50671437 |
| 31 | LRRK2 | 1.49004633 |
| 32 | EEF2K | 1.40036651 |
| 33 | ARAF | 1.38212988 |
| 34 | GRK6 | 1.36761381 |
| 35 | ITK | 1.33912449 |
| 36 | CSK | 1.32325162 |
| 37 | LCK | 1.30220450 |
| 38 | TGFBR1 | 1.29998071 |
| 39 | IRAK3 | 1.27479725 |
| 40 | FLT3 | 1.27316937 |
| 41 | LYN | 1.26250812 |
| 42 | IKBKB | 1.22571896 |
| 43 | MAP3K10 | 1.21806284 |
| 44 | MST4 | 1.20938522 |
| 45 | PRKD2 | 1.17574107 |
| 46 | MATK | 1.16188554 |
| 47 | MAP2K3 | 1.16003381 |
| 48 | MST1R | 1.15332261 |
| 49 | TAOK3 | 1.14158077 |
| 50 | EIF2AK3 | 1.12154415 |
| 51 | NLK | 1.07444252 |
| 52 | TAOK1 | 1.06652752 |
| 53 | RPS6KB2 | 1.06423580 |
| 54 | RPS6KA4 | 1.06312101 |
| 55 | TIE1 | 1.05559326 |
| 56 | PIM1 | 1.01435371 |
| 57 | MYLK | 0.99746814 |
| 58 | MAP3K1 | 0.96668705 |
| 59 | HCK | 0.96009220 |
| 60 | CLK1 | 0.95111372 |
| 61 | FGFR3 | 0.94423757 |
| 62 | STK16 | 0.90861384 |
| 63 | CDC42BPA | 0.90367153 |
| 64 | MAP3K11 | 0.90340229 |
| 65 | RIPK4 | 0.90293645 |
| 66 | FES | 0.89083635 |
| 67 | MAPKAPK3 | 0.86535211 |
| 68 | MAP3K6 | 0.85446797 |
| 69 | EIF2AK1 | 0.84830438 |
| 70 | PAK4 | 0.84138632 |
| 71 | SCYL2 | 0.82142357 |
| 72 | ICK | 0.81310476 |
| 73 | DAPK1 | 0.79656470 |
| 74 | PDPK1 | 0.78653040 |
| 75 | ACVR1B | 0.78223624 |
| 76 | TESK1 | 0.74262321 |
| 77 | LIMK1 | 0.72932173 |
| 78 | BMX | 0.72423134 |
| 79 | SIK3 | 0.71854015 |
| 80 | STK38 | 0.71040005 |
| 81 | KSR2 | 0.70455624 |
| 82 | MAPK11 | 0.68111458 |
| 83 | VRK2 | 0.67087698 |
| 84 | JAK2 | 0.66532205 |
| 85 | CDK19 | 0.66503650 |
| 86 | CHUK | 0.65594233 |
| 87 | PTK2 | 0.62505237 |
| 88 | MAP2K2 | 0.60446990 |
| 89 | EPHB1 | 0.59825258 |
| 90 | RIPK1 | 0.58730477 |
| 91 | TTN | 0.58723360 |
| 92 | SIK1 | 0.57483154 |
| 93 | MARK2 | 0.56782485 |
| 94 | MAPK15 | 0.56011786 |
| 95 | PKN2 | 0.55236179 |
| 96 | IRAK2 | 0.52668658 |
| 97 | MAP3K8 | 0.52090033 |
| 98 | PDGFRA | 0.51198556 |
| 99 | PDK1 | 0.51142586 |
| 100 | CDK6 | 0.50805695 |
| 101 | TNK2 | 0.50137615 |
| 102 | CDK4 | 0.48808222 |
| 103 | EPHA2 | 0.48427803 |
| 104 | DDR2 | 0.47846073 |
| 105 | VRK1 | 0.47326747 |
| 106 | HIPK2 | 0.47295053 |
| 107 | RPS6KA6 | 0.46472866 |
| 108 | DYRK1B | 0.45649305 |
| 109 | CDK8 | 0.45400162 |
| 110 | MAPK4 | 0.45371942 |
| 111 | TRPM7 | 0.44284424 |
| 112 | FGR | 0.43890663 |
| 113 | RPS6KA2 | 0.43211989 |
| 114 | NME1 | 0.42259903 |
| 115 | NEK9 | 0.41319103 |
| 116 | ABL1 | 0.40826302 |
| 117 | PAK1 | 0.40521360 |
| 118 | ABL2 | 0.39918048 |
| 119 | PRKCD | 0.39165552 |
| 120 | NTRK1 | 0.39117916 |
| 121 | LMTK2 | 0.38303124 |
| 122 | CDK12 | 0.38203740 |
| 123 | MAP3K13 | 0.36022310 |
| 124 | DAPK3 | 0.35468947 |
| 125 | PTK6 | 0.35465519 |
| 126 | ILK | 0.35065573 |
| 127 | PRKG2 | 0.34911335 |
| 128 | CDK7 | 0.33942539 |
| 129 | RPS6KC1 | 0.33856073 |
| 130 | RPS6KL1 | 0.33856073 |
| 131 | DYRK3 | 0.33686314 |
| 132 | MAP2K6 | 0.33478809 |
| 133 | TLK1 | 0.33305460 |
| 134 | BUB1 | 0.33150983 |
| 135 | MAPKAPK2 | 0.32941992 |
| 136 | BCKDK | 0.31785808 |
| 137 | ATR | 0.30254707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.62517986 |
| 2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.66757469 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58740273 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.49639163 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.42328002 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.35882726 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.31426425 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29270028 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.28350892 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25348474 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.21826828 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15890469 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.12317245 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.95514286 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.82290802 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79276959 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74364358 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.71885098 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.64037237 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.62890608 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61722436 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61185122 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52746905 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.50673090 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.46741705 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46419651 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46142560 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.41113106 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39174546 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.37047305 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36119171 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34045815 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29013456 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.27385245 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23972611 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.22352613 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18392402 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16721318 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.16351851 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14629981 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.13375440 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12554177 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12147117 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.11702309 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11676849 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.10348809 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06914523 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06519775 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.05235846 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03771960 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 1.02468677 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 1.01558424 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99187053 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98268847 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.98074437 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96678841 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95849282 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.95838087 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95633419 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95268797 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95103646 |
| 62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90649664 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89472344 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89471807 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89249484 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87905151 |
| 67 | Spliceosome_Homo sapiens_hsa03040 | 0.87468551 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.87172078 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87042304 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85413868 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.85203809 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.82246287 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80015421 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77099346 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76833109 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.76572355 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.75843286 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75100997 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74117400 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72609325 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71713515 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71099495 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70887705 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70875308 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70463255 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68254343 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63910686 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61285969 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60865991 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57628784 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56326319 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.54229363 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54046151 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53775213 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53489837 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52737866 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52348907 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47831167 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46289894 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46161895 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46012994 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44665855 |
| 103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43906391 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.42808445 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42149387 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42123129 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40608952 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39049851 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.37985009 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37211243 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36791988 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36412464 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36122059 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.35307463 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33996132 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33173973 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32953445 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32341886 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32000326 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31972208 |
| 121 | Cell cycle_Homo sapiens_hsa04110 | 0.30278103 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28721175 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.28232604 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26977577 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26354878 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.25108096 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22209995 |

